Q4 2024 Earnings Call Transcript March 24, 2025 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.15. Operator: Good morning, and welcome to the ...
A new report reflects how the industry, which experienced a rush of entrants following approval of State Question 788 in 2018 ...
Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...
Harrisburg lawmakers launched a bipartisan effort to address a financial crisis that is forcing many of the state’s emergency ...
As the number of cases in the Texas measles outbreak continues to climb, Oklahoma is now reporting four cases, according to ...
The presence of anti-CD4 autoantibodies in treatment-naive patients with advanced HIV was associated with a decreased rate of CD4 reconstitution following ART initiation.
Hospitals say AI is helping their nurses, while unions argue the technology is overriding nurses' expertise and degrading quality of care.
Abivax Announces Full Year 2024 Financial Results • Cash balance of EUR 144.2M as of December 31, 2024; cash runway into Q4 2025Full ...
California health officials confirm human cases of bird flu linked to Central Valley dairy farms, with 37 workers and one ...
EQS-News: ABIVAX / Key word (s): Annual Results Abivax Announces Full Year 2024 Financial Results 24.03.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.
Weed users are much more likely to suffer a heart attack, stroke or other life-threatening heart condition than people who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results